Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ritchie

Showing results (351-360 of 395) with videos related to

Pageof 40
Sort By:
Current Biology : CB|February 7, 2017
Circadian Entrainment to the Natural Light-Dark Cycle across Seasons and the WeekendEllen R Stothard, Andrew W McHill, Christopher M Depner, et al.
British Journal of Haematology|May 25, 2013
Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosisDaniel J DeAngelo, Ruben A Mesa, Warren Fiskus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemiaGail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Haematologica|May 5, 2018
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemiaGail J Roboz, Ellen K Ritchie, Yulia Dault, et al.
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Sleep|May 10, 2019
Trait-like vulnerability of higher-order cognition and ability to maintain wakefulness during combined sleep restriction and circadian misalignmentKate E Sprecher, Hannah K Ritchie, Tina M Burke, et al.
Blood|May 27, 2011
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AMLJoseph M Scandura, Gail J Roboz, Michelle Moh, et al.
European Journal of Neurology|March 5, 2019
Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution?H J M Majoie, J van Gaalen, D M L Verstegen, et al.
Journal of the American Chemical Society|August 28, 2010
A metal-organic framework with a covalently prefabricated porous organic linkerShashikala I Swamy, John Bacsa, James T A Jones, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Pageof 40

Showing results (351-360 of 395) with videos related to

Sort By:
Pageof 40
Current Biology : CB|February 7, 2017
Circadian Entrainment to the Natural Light-Dark Cycle across Seasons and the WeekendEllen R Stothard, Andrew W McHill, Christopher M Depner, et al.
British Journal of Haematology|May 25, 2013
Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosisDaniel J DeAngelo, Ruben A Mesa, Warren Fiskus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemiaGail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Haematologica|May 5, 2018
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemiaGail J Roboz, Ellen K Ritchie, Yulia Dault, et al.
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Sleep|May 10, 2019
Trait-like vulnerability of higher-order cognition and ability to maintain wakefulness during combined sleep restriction and circadian misalignmentKate E Sprecher, Hannah K Ritchie, Tina M Burke, et al.
Blood|May 27, 2011
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AMLJoseph M Scandura, Gail J Roboz, Michelle Moh, et al.
European Journal of Neurology|March 5, 2019
Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution?H J M Majoie, J van Gaalen, D M L Verstegen, et al.
Journal of the American Chemical Society|August 28, 2010
A metal-organic framework with a covalently prefabricated porous organic linkerShashikala I Swamy, John Bacsa, James T A Jones, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Pageof 40